Bull SB - Search Results

1

Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors.

Bane AL, Pinnaduwage D, Colby S, Reedijk M, Egan SE, Bull SB, O'Malley FP, Andrulis IL. Bane AL, et al. Among authors: bull sb. Breast Cancer Res Treat. 2009 Sep;117(1):183-91. doi: 10.1007/s10549-008-0087-1. Epub 2008 Jun 18. Breast Cancer Res Treat. 2009. PMID: 18563556 Free PMC article.

2

Two variants of the CIP1/WAF1 gene occur together and are associated with human cancer.

Mousses S, Ozçelik H, Lee PD, Malkin D, Bull SB, Andrulis IL. Mousses S, et al. Among authors: bull sb. Hum Mol Genet. 1995 Jun;4(6):1089-92. doi: 10.1093/hmg/4.6.1089. Hum Mol Genet. 1995. PMID: 7655464

3

Comparison of evidence for linkage from different analytic methods.

Bull SB, Pinnaduwage D, Shin J, Xie F, Tritchler D. Bull SB, et al. Genet Epidemiol. 1997;14(6):965-70. doi: 10.1002/(SICI)1098-2272(1997)14:6<965::AID-GEPI67>3.0.CO;2-J. Genet Epidemiol. 1997. PMID: 9433608 Clinical Trial.

4

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group.

Andrulis IL, Bull SB, Blackstein ME, Sutherland D, Mak C, Sidlofsky S, Pritzker KP, Hartwick RW, Hanna W, Lickley L, Wilkinson R, Qizilbash A, Ambus U, Lipa M, Weizel H, Katz A, Baida M, Mariz S, Stoik G, Dacamara P, Strongitharm D, Geddie W, McCready D. Andrulis IL, et al. Among authors: bull sb. J Clin Oncol. 1998 Apr;16(4):1340-9. doi: 10.1200/JCO.1998.16.4.1340. J Clin Oncol. 1998. PMID: 9552035

5

Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers.

Ozçelik H, To MD, Couture J, Bull SB, Andrulis IL. Ozçelik H, et al. Among authors: bull sb. Int J Cancer. 1998 Jul 3;77(1):1-6. doi: 10.1002/(sici)1097-0215(19980703)77:1<1::aid-ijc1>3.0.co;2-y. Int J Cancer. 1998. PMID: 9639385

6

MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study.

Wunder JS, Bull SB, Aneliunas V, Lee PD, Davis AM, Beauchamp CP, Conrad EU, Grimer RJ, Healey JH, Rock MJ, Bell RS, Andrulis IL. Wunder JS, et al. Among authors: bull sb. J Clin Oncol. 2000 Jul;18(14):2685-94. doi: 10.1200/JCO.2000.18.14.2685. J Clin Oncol. 2000. PMID: 10894867

7

p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast.

Done SJ, Eskandarian S, Bull S, Redston M, Andrulis IL. Done SJ, et al. J Natl Cancer Inst. 2001 May 2;93(9):700-4. doi: 10.1093/jnci/93.9.700. J Natl Cancer Inst. 2001. PMID: 11333292

8

p53 missense but not truncation mutations are associated with low levels of p21(CIP1/WAF1) mRNA expression in primary human sarcomas.

Mousses S, Gokgoz N, Wunder JS, Ozcelik H, Bull S, Bell RS, Andrulis IL. Mousses S, et al. Br J Cancer. 2001 Jun 15;84(12):1635-9. doi: 10.1054/bjoc.2001.1844. Br J Cancer. 2001. PMID: 11401317 Free PMC article.

9

Angiotensinogen M235T genotype predicts progression in chronic renal allograft dysfunction.

Prasad GV, Pinnaduwage D, Parkes RK, Midgley J, Balfe JW, Hegele RA, Bull SB, Cole EH, Logan AG. Prasad GV, et al. Among authors: bull sb. Transplantation. 2003 Jan 27;75(2):209-16. doi: 10.1097/01.TP.0000040866.14123.05. Transplantation. 2003. PMID: 12548125

10

The combination of p53 mutation and neu/erbB-2 amplification is associated with poor survival in node-negative breast cancer.

Bull SB, Ozcelik H, Pinnaduwage D, Blackstein ME, Sutherland DA, Pritchard KI, Tzontcheva AT, Sidlofsky S, Hanna WM, Qizilbash AH, Tweeddale ME, Fine S, McCready DR, Andrulis IL. Bull SB, et al. J Clin Oncol. 2004 Jan 1;22(1):86-96. doi: 10.1200/JCO.2004.09.128. J Clin Oncol. 2004. PMID: 14701769

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters